Advances in psychopharmacology have revolutionalized the management of emotional and behavioral disorders in children and adolescents. Recent developments in pediatric psychopharmacology and the prevalence of pharmacotherapy for various psychological disorders in children are examined, and clinical updates for classes of psychotropics are provided. Issues including monitoring and assessing drug effects, acceptability and satisfaction, and the social, political, and cultural issues surrounding the use of psychotropics in children are discussed. The authors conclude that the current clinical use of psychotropics in children exceeds extant efficacy and safety data. The involvement of practicing psychologists in pediatric psychopharmacology and the need for a firm empirical foundation for pediatric psychopharmacology are also discussed.
No takes yet. Share an insight, caveat, or question.
Brown et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: